Ishita Drugs & Industries Ltd — Updates, 30-05-2025: Company Update

Ishita Drugs & Industries Ltd has announced a board meeting outcome where it approved the financial results for the quarter and year ended March 31, 2025, along with the Directors' Report, Corporate Governance Report, and related AGM notice. The board approved the re-appointment of internal auditors for FY 2025-26 and appointed M/s Meenu Maheshwari & Associates as Secretarial Auditor for five years, subject to shareholder approval. The statutory auditors issued an audit report with an unmodified opinion. The company reported total assets of Rs. 1629.58 lakh, primarily consisting of current assets, with equity share capital of Rs. 299.03 lakh. The cash flow statement showed net cash outflow from operating activities at Rs. 363.71 lakh and cash inflow from financing activities at Rs. 432.74 lakh, resulting in a slight increase in cash balance.